Medicine & Life Sciences
Cost-Benefit Analysis
100%
Bioterrorism
83%
HIV
79%
Positron-Emission Tomography
77%
Congenital Syphilis
76%
Syphilis
65%
Costs and Cost Analysis
57%
Tomography
54%
Highly Active Antiretroviral Therapy
46%
Meta-Analysis
45%
Prenatal Diagnosis
44%
Solitary Pulmonary Nodule
42%
Quality-Adjusted Life Years
40%
efavirenz
38%
Nontuberculous Mycobacteria
37%
Sensitivity and Specificity
37%
Positron Emission Tomography Computed Tomography
35%
Lung
34%
Bronchiectasis
34%
Information Technology
34%
Early Detection of Cancer
32%
Point-of-Care Systems
32%
Reagins
32%
Africa South of the Sahara
31%
Data Systems
29%
Acquired Immunodeficiency Syndrome
29%
Radiologists
29%
Lung Neoplasms
27%
Pulmonary Artery
26%
Non-Small Cell Lung Carcinoma
25%
Registries
25%
Perinatal Death
24%
Risk Assessment
24%
Dilatation
24%
China
23%
Public Health
23%
Low Birth Weight Infant
23%
Cohort Studies
22%
Life Expectancy
22%
Fats
21%
Fibrosis
21%
Systematic Reviews
21%
Biomarkers
18%
Lymph Nodes
17%
Pregnant Women
17%
Stillbirth
16%
Sentinel Surveillance
15%
Live Birth
15%
Information Storage and Retrieval
13%
Survival
13%
Social Sciences
congenital syphilis
24%
information technology
20%
costs
16%
pregnant women
13%
pregnancy
13%
public health
12%
life expectancy
11%
infant
10%
event
9%
death
9%
clinician
8%
appropriate treatment
5%
labor costs
5%
labor supply
5%
